Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Ochała, G. Smołka, W. Wojakowski, D. Dudek, A. Dziewierz, Z. Królikowski, Z. Gąsior, M. Tendera (2004)
The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction.The Journal of invasive cardiology, 16 12
M. Cavender, Sarah Milford-Beland, M. Roe, E. Peterson, W. Weintraub, S. Rao (2009)
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).The American journal of cardiology, 104 4
G. Tarantini, G. D’Amico, S. Brener, P. Tellaroli, M. Basile, Alessandro Schiavo, M. Mojoli, C. Fraccaro, A. Marchese, G. Musumeci, G. Stone (2016)
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis.JACC. Cardiovascular interventions, 9 17
Windecker (2014)
2014 ESC/EACTS Guidelines on Myocardial Revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Eur Heart J, 35
L. Politi, F. Sgura, R. Rossi, D. Monopoli, E. Guerri, C. Leuzzi, F. Bursi, G. Sangiorgi, M. Modena (2009)
A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-upHeart, 96
D. Carlo, Sansa Mara, Airoldi Flavio, Sheiban Imad, Manari Antonio, Petroni Anna, P. Emanuela, De Stefano, Ramondo Angelo, Colusso Stefania, Formosa Anna, Cernigliaro Carmelo, Colombo Antonio, N. Monzini, M. Bonardi (2004)
Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) StudyInternational Journal of Cardiovascular Interventions, 6
C. Hanratty, Y. Koyama, H. Rasmussen, G. Nelson, P. Hansen, M. Ward (2002)
Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization.Journal of the American College of Cardiology, 40 5
R. Tarasov, V. Ganyukov, A. Protopopov, O. Barbarash, L. Barbarash (2014)
Six month results of randomized clinical trial: Multivessel stenting versus staged revascularization for ST-elevation myocardial infarction patients with second generation drug eluting stents
K. Bainey, S. Mehta, T. Lai, R. Welsh (2014)
Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.American heart journal, 167 1
Larissa Shamseer, D. Moher, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, L. Stewart, Prisma-P Group (2016)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanationBritish Medical Journal, 354
T. Engstrøm, H. Kelbæk, S. Helqvist, D. Høfsten, L. Kløvgaard, L. Holmvang, E. Jørgensen, F. Pedersen, K. Saunamäki, P. Clemmensen, O. Backer, J. Ravkilde, H. Tilsted, A. Villadsen, J. Aarøe, S. Jensen, B. Raungaard, L. Køber (2015)
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThe Lancet, 386
I. Elgendy, T. Huo, Ahmed Mahmoud, A. Bavry (2015)
Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials.International journal of cardiology, 186
Elgendy (2016)
Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: an updated meta-analysis of randomized trialsCatheter Cardiovasc Interv, 88
M. Egger, G. Smith, Martin Schneider, C. Minder (1997)
Bias in meta-analysis detected by a simple, graphical testBMJ, 315
Shamseer (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanationBMJ, 349
Khagendra Dahal, Jharendra Rijal, Raju Panta, Juyong Lee, M. Azrin, Robert Lootens (2014)
Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials.Cardiovascular revascularization medicine : including molecular interventions, 15 8
JPT Higgins, S. Green (2008)
Cochrane Handbook for Systemic Review of Interventions
P. Sorajja, B. Gersh, D. Cox, M. McLaughlin, P. Zimetbaum, C. Costantini, T. Stuckey, J. Tcheng, R. Mehran, A. Lansky, C. Grines, G. Stone (2007)
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.European heart journal, 28 14
Y. Ohashi, S. Kawashima, Takao Mori, M. Terashima, Shinobu Ichikawa, Junya Ejiri, K. Awano (2006)
Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.International journal of cardiology, 112 1
M. Chan, F. Andreotti, R. Becker (2008)
Hypercoagulable States in Cardiovascular DiseaseCirculation, 118
M. Iqbal, I. Nadra, L. Ding, A. Fung, E. Aymong, A. Chan, S. Hodge, A. Siega, S. Robinson, British Investigators (2017)
Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.JACC. Cardiovascular interventions, 10 1
R. Kornowski, R. Mehran, G. Dangas, E. Nikolsky, A. Assali, B. Claessen, B. Gersh, S. Wong, B. Witzenbichler, G. Guagliumi, D. Dudek, M. Fahy, A. Lansky, G. Stone, Horizons-Ami Investigators (2011)
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.Journal of the American College of Cardiology, 58 7
I. Elgendy, X. Wen, Ahmed Mahmoud, A. Bavry (2016)
CORONARY ARTERY DISEASE Original Studies Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials
R. Tarasov, V. Ganyukov, A. Protopopov, O. Barbarash, L. Barbarash (2014)
Six Month Results of Randomized Clinical trial: Multivessel Stenting in Primary Percutaneous Coronary Intervention and Staged Revascularization for ST-Elevation Myocardial Infarction Patients with Second Generation Drug Eluting StentsClinical Medicine & Research, 3
Walid Maamoun, Nabil Elkhaeat, Rasha Elarasy (2011)
Safety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel diseaseThe Egyptian Heart Journal, 63
G. Heusch, P. Kleinbongard, D. Böse, B. Levkau, M. Haude, R. Schulz, R. Erbel (2009)
Coronary microembolization: from bedside to bench and back to bedside.Circulation, 120 18
E. Hannan, Zaza Samadashvili, G. Walford, D. Holmes, A. Jacobs, N. Stamato, F. Venditti, Samin Sharma, S. King (2010)
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.JACC. Cardiovascular interventions, 3 1
D. Wald, J. Morris, N. Wald, Alexander Chase, R. Edwards, L. Hughes, C. Berry, K. Oldroyd (2013)
Randomized trial of preventive angioplasty in myocardial infarction.The New England journal of medicine, 369 12
P. Kolh, S. Windecker, F. Alfonso, J. Collet, J. Cremer, V. Falk, G. Filippatos, C. Hamm, S. Head, P. Jüni, A. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F. Neumann, D. Richter, P. Schauerte, M. Uva, G. Stefanini, D. Taggart, L. Torracca, M. Valgimigli, W. Wijns, A. Witkowski, J. Zamorano, S. Achenbach, H. Baumgartner, Jeroen Bax, H. Bueno, V. Dean, C. Deaton, Ç. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. Hoes, P. Kirchhof, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M. Piepoli, P. Ponikowski, P. Sirnes, J. Tamargo, M. Tendera, A. Torbicki, S. Windecker, J. Pepper, A. Anyanwu, L. Badimón, J. Bauersachs, A. Baumbach, F. Beygui, N. Bonaros, M. Carlo, D. Dobrev, J. Dunning, É. Eeckhout, S. Gielen, P. Kirchhof, H. Luckraz, H. Mahrholdt, G. Montalescot, D. Paparella, A. Rastan, M. Sanmartin, P. Sergeant, S. Silber, J. Tamargo, Jurrien Berg, H. Thiele, R. Geuns, H. Wagner, S. Wassmann, O. Wendler (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of PercutaneousEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 46 4
G. Dangas, J. George, W. Weintraub, J. Popma (2010)
Timing of staged percutaneous coronary intervention in multivessel coronary artery disease.JACC. Cardiovascular interventions, 3 10
Glenn Levine, Eric Bates, James Blankenship, Steven Bailey, J. Bittl, Bojan Cercek, Charles Chambers, Stephen Ellis, Robert Guyton, Steven Hollenberg, U. Khot, Richard Lange, Laura Mauri, Roxana Mehran, I. Moussa, D. Mukherjee, Henry Ting, Patrick O’Gara, F. Kushner, D. Ascheim, R. Brindis, Donald Casey, Mina Chung, J. Lemos, Deborah Diercks, James Fang, Barry Franklin, Christopher Granger, H. Krumholz, Jane Linderbaum, David Morrow, L. Newby, Joseph Ornato, Narith Ou, M. Radford, J. Tamis-Holland, C. Tommaso, C. Tracy, Y. Woo, David Zhao (2016)
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial InfaJournal of the American College of Cardiology, 67 10
J. Higgins, S. Thompson, J. Deeks, D. Altman (2003)
Measuring inconsistency in meta-analysesBMJ : British Medical Journal, 327
A. Gershlick, J. Khan, D. Kelly, J. Greenwood, T. Sasikaran, N. Curzen, D. Blackman, M. Dalby, Kathryn Fairbrother, W. Banya, Duolao Wang, M. Flather, S. Hetherington, A. Kelion, S. Talwar, M. Gunning, R. Hall, H. Swanton, G. Mccann (2015)
Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel DiseaseJournal of the American College of Cardiology, 65
D. Martí, J. Mestre, L. Salido, M. Esteban, E. Casas, J. Pey, M. Sanmartin, R. Hernández-Antolı́n, J. Zamorano (2014)
Incidence, angiographic features and outcomes of patients presenting with subtle ST-elevation myocardial infarction.American heart journal, 168 6
INTRODUCTIONMultivessel coronary artery disease (CAD) is seen in almost 50% of patients presenting with ST‐elevation myocardial infarction (STEMI). This is associated with worse prognosis compared to patients presenting with single‐vessel disease. Recent randomized control trials such as Preventive Angioplasty in Acute Myocardial Infarction (PRAMI), Complete versus Lesion only Primary Percutaneous Coronary Intervention (CvLPRIT), and Third Danish Study of Optimal Acute Treatment of Patients with STEMI (DANAMI‐3‐PRIMULTI) along with prior metanalyses have demonstrated that complete revascularization significantly reduced adverse cardiovascular events compared to infarct‐related artery (IRA) percutaneous coronary intervention (PCI) alone. To date, it is unclear whether the non‐IRA PCI should be done during the index procedure or as a staged revascularization procedure. While the American College of Cardiology (ACC)/American Heart Association (AHA) upgraded the recommendation for non‐IRA PCI at the time of index procedure or as staged procedure from III to IIb, giving an equal level of recommendation to both index procedure and staged revascularization, the European Society of Cardiology (ESC) gives a IIa recommendation for staged revascularization of non‐IRA and IIb for index procedure revascularization. A recent metanalysis of observational and randomized controlled studies by Tarantini et al and a British Columbia Cardiac Registry study have both demonstrated
Journal of Interventional Cardiology – Wiley
Published: Oct 1, 2017
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.